Inc. Ctt Pharmaceutical Holdings Insider Trades & Stock Holdings

CEO · Ctt Pharmaceutical Holdings, Inc. · Latest filing Oct 6, 2026

Inc. Ctt Pharmaceutical Holdings, CEO at Ctt Pharmaceutical Holdings, Inc. has 3 Form 4 trades on file since Sep 22, 2026. Open-market activity: 3 purchases ($845) and 0 sales ($0), net +$845. Latest filing: acquired 3.70K shares of $CTTH on Oct 6, 2026 at $0.06.

Trades on file

3

Open-market bought

$845

Open-market sold

$0

Net open-market

+$845

Latest filing

Oct 6, 2026

All insider trades by Inc. Ctt Pharmaceutical Holdings

Date	Ticker	Type	Shares	Price	Value	Owned after	ΔOwn	1W	1M	6M	Role	Filing	Story
Oct 6, 2026	$CTTH	Buy (Open-market buy)	3.70K	$0.06	$203.50						CEO		—
Sep 28, 2026	$CTTH	Buy (Open-market buy)	3.40K	$0.06	$187						CEO		—
Sep 22, 2026	$CTTH	Buy (Open-market buy)	10.10K	$0.04	$454.50						CEO		—

"Buy" means shares acquired on the Form 4 (including grants and option exercises); "Sell" means shares disposed. 1W / 1M / 6M = how the stock moved after the trade.

Stocks Inc. Ctt Pharmaceutical Holdings traded

• $CTTH

Frequently asked questions

Has Inc. Ctt Pharmaceutical Holdings been buying or selling stock?

Inc. Ctt Pharmaceutical Holdings has 3 open-market purchases and 0 open-market sales on file, net +$845. Grants, option exercises and tax withholding are listed separately because they are not open-market trades.

What was Inc. Ctt Pharmaceutical Holdings's latest insider trade?

acquired 3.70K shares of $CTTH on Oct 6, 2026 at $0.06.

Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.